Product Name :
Anti-SIGLEC3/CD33(Lintuzumab Biosimilar) Antibody
Applications:
ELISA,Flow Cyt
Reactivity :
Human SIGLEC3/CD33/p67
Conjugate:
Unconjugated
Advantages :
High lot-to-lot consistencyIncreased sensitivity and higher affinityAnimal-free production
Description:
| Description: Anti-SIGLEC3/CD33(Lintuzumab Biosimilar) Antibody is a biosimilar antibody directed against Human SIGLEC3/CD33/p67. | Isotype: Human IgG1 | Conjugate: Unconjugated | Specificity: Human SIGLEC3/CD33/p67 | Clonality: Monoclonal | Purity: Recombinant Expression and Affinity purified | Concentration: 1mg/ml | Formation: Liquid, 10mM PBS (pH 7.5) | Storage: Store at –20 °C, (Avoid freeze/thaw cycles)
Description2 :
Anti-SIGLEC3/CD33(Lintuzumab Biosimilar) Antibody is a biosimilar antibody directed against Human SIGLEC3/CD33/p67.{{447415-26-1} medchemexpress|{447415-26-1} Protocol|{447415-26-1} In Vivo|{447415-26-1} manufacturer}
Immunogen:
Host :
Isotype:
Human IgG1
Purity :
Recombinant Expression and Affinity purified
Buffer :
Storage :
Function:
ELISA: 1:5000-1:20000Flow Cyt: 1:200-1:1000Other tested applications.{{2140211-48-7} web|{2140211-48-7} Biological Activity|{2140211-48-7} In Vitro|{2140211-48-7} supplier} Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc.PMID:30725688 The actual dilution used must be determined empirically.
